Technology Assisted Treatment for Trichotillomania

Part of paid clinical trials in Kent, Ohio.

Sponsor
HabitAware Inc.
Study ID
NCT05118633
Status
Recruiting

Conditions

  • Trichotillomania

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Keen2 bracelet — DEVICE
    Participants will receive an awareness bracelet (Keen2) which vibrates upon detection of hair pulling motion, supporting behavior therapy for hair pulling delivered by the Keen2 app.
  • Reminder bracelet — DEVICE
    Participants will receive a non-vibrating bracelet to wear as a visual reminder not to pull.
  • Keen2 app — BEHAVIORAL
    Participants will be given access to a smartphone app. The bracelet and app work together to implement key features of habit reversal training for TTM, including psychoeducation, awareness training, competing response training, and personalized just-in-time stimulus control and other behavioral strategy reminders.
  • Health Reminders App — BEHAVIORAL
    Participants will be given access to a smartphone app that will prompt them to log their context (e.g., location and activity) throughout the day and provide general health tips.

Study Details

The investigators are testing two digital health interventions for trichotillomania (TTM), via a randomized trial design.

Key Dates

Start date
May 15, 2026
Status verified
May 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
90 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Keen2 bracelet and app
    8-week intervention involving a wrist-worn motion detection device (Keen2 bracelet) and accompanying smartphone app that delivers components of behavior therapy for TTM.
  • Placebo Comparator: Reminder bracelet and health tips app
    8-week intervention involving a wrist-worn reminder device (non-vibrating bracelet) and accompanying smartphone app that prompts for general context logging and delivers general health tips.

Primary Outcome Measure

Clinician-rated trichotillomania (TTM) symptom severity at endpoint (week 8) [ Time Frame: Eight weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Department of Psychological SciencesKentOhio44242
Christopher Flessner, PhD
(330) 672-2200

Find similar trials in Kent, OH

Related Studies